Efstathiou, Jason A <br/><br/>
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.  [electronic resource] 

 -  European urology  Oct 2008 
 - 816-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0302-2838 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2008.01.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Cardiovascular Diseases--mortality<br/>Flutamide--adverse effects<br/>Goserelin--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prostatic Neoplasms--drug therapy<br/>Time Factors